Okina A, Hidaka S, Tashiro M, Abe K
Department of Oral Biochemistry, Fukuoka Dental College, Japan.
J Dent Res. 1993 May;72(5):897-906. doi: 10.1177/00220345930720051101.
The effects of different doses of p-tyramine injected i.v. and i.p. on salivary flow rates and proteins secreted by the submandibular glands of rats were studied with and without various types of autonomic blockers and two enzyme inhibitors. The salivary flow rates and the amounts of protein secreted progressively increased with increasing doses injected both i.v. and i.p., whereas they were dramatically reduced with all autonomic blockers except the lowest doses of beta-blockers, atropine, and yohimbine. Salivation in response to p-tyramine injected i.v. and i.p. was completely abolished by simultaneous injections of both prazosin and propranolol. The concentration of protein was not dose-dependent and was not reduced by yohimbine and phenoxybenzamine at almost all doses used. However, prazosin significantly increased the protein concentration. Protease activities were dose-dependent but were significantly reduced with alpha-blockers other than yohimbine, and with most beta-blockers. The proteins secreted in response to p-tyramine at all doses injected i.v. and i.p. were of the alpha-type except with the lowest dose injected i.p. However, the alpha-type was completely replaced by the beta-type in the presence of all alpha-blockers except yohimbine, but not with beta-blockers, atropine, or two enzyme inhibitors. Pargyline, a monoamine-oxidase inhibitor, but not disulfiram, a dopamine-beta-hydroxylase inhibitor, affected all parameters except the type of protein. Thus, p-tyramine may activate both the alpha 1- and beta 1-adrenoceptors in the submandibular glands of rats directly or indirectly.
研究了静脉注射和腹腔注射不同剂量的对酪胺对大鼠颌下腺唾液分泌速率和分泌蛋白的影响,实验中使用了各种类型的自主神经阻滞剂和两种酶抑制剂。静脉注射和腹腔注射时,随着注射剂量的增加,唾液分泌速率和蛋白分泌量逐渐增加;然而,除了最低剂量的β受体阻滞剂、阿托品和育亨宾外,所有自主神经阻滞剂都会使其显著降低。同时注射哌唑嗪和普萘洛尔可完全消除静脉注射和腹腔注射对酪胺引起的唾液分泌。蛋白浓度不依赖于剂量,几乎在所有使用的剂量下,育亨宾和酚苄明都不会使其降低。然而,哌唑嗪可显著提高蛋白浓度。蛋白酶活性依赖于剂量,但除育亨宾外的α受体阻滞剂和大多数β受体阻滞剂可使其显著降低。静脉注射和腹腔注射所有剂量的对酪胺所分泌的蛋白,除腹腔注射最低剂量外,均为α型。然而,在除育亨宾外的所有α受体阻滞剂存在的情况下,α型蛋白完全被β型蛋白取代,但β受体阻滞剂、阿托品或两种酶抑制剂不会导致这种情况。单胺氧化酶抑制剂帕吉林而非多巴胺-β-羟化酶抑制剂双硫仑会影响除蛋白类型外的所有参数。因此,对酪胺可能直接或间接激活大鼠颌下腺中的α1和β1肾上腺素能受体。